On the page, you can see the best doctors for pulmonary fibrosis treatment. International patients pick these specialists for pulmonary fibrosis treatment due to the following reasons:
Innovative treatment methods
Minimally invasive surgeries
Advantages of these specialists for pulmonary fibrosis treatment:
Up to 95% success rate. The doctors listed below apply the latest techniques to achieve such a result.
International accreditation. The pulmonary fibrosis treatment facilities have international healthcare accreditations and certificates. It means that they provide the pulmonary fibrosis treatment in accordance with the strict world treatment protocols.
The pulmonary fibrosis treatment is already possible at a price from €14,000. Please send us your inquiry with a current x-ray image to get a detailed estimate cost.
German Medical Group is a medical platform that does not represent interests of specific hospitals or doctors.
Our services do not affect the price for pulmonary fibrosis treatment procedures, you pay the bill right in the chosen clinic.
Submit a request on German Medical Group website - our manager will give you all the info regarding a particular doctor for pulmonary fibrosis treatment or hospital. This consultation is FREE. Together we choose the best specialist for pulmonary fibrosis treatment for your case. With German Medical Group you avoid waiting lists, get 24/7 support until your coming back home. Learn more about us here.
Follow these steps to choose the best doctor for pulmonary fibrosis treatment:
Learn the info about doctors for pulmonary fibrosis treatment listed below. It represents top specialists in Europe.
Submit a request on German Medical Group specifying the purpose of the treatment.
Our manager will call you back to book the chosen specialist for pulmonary fibrosis treatment or offer another one according to the diagnosis, health condition, and financial ability.
If you approve the chosen doctor for pulmonary fibrosis treatment, our manager schedules the date of your arrival.
Hannover Medical School scientists investigate fibrosis of the lungs
A working group of the Hannover Medical School (MHH) around Danny Jonigk from the Institute of Pathology wants to develop therapeutic options for previously incurable lung diseases. In the next five years, the team will be examining around 700 diseased lungs, which will be taken from patients by transplants. In 2017, around 120 lungs were transplanted at the MHH.
Jonigk uses these lungs to study, in particular, the mechanism of so-called fibrosis, which is at the center of the disease. This is the abnormal proliferation of connective tissue in the lungs that causes the lung to stop functioning properly. Macrophages play a key role in this process. These cells are to be modified by means of a so-called gene scissors so that they can halt or reverse the course of the disease.
In the long term, these macrophages should be administered to patients by infusion or inhalation for therapeutic purposes. The scientists work very closely with working groups of the MHH Clinic for Cardiac, Thoracic, Transplantation and Vascular Surgery, the MHH Clinic for Pulmonology and the MHH Institute for Diagnostic and Interventional Radiology.